Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
2015 · JAMA · 494 citations
https://doi.org/10.1001/jama.2014.5985
K
Katja Harbst
Lund University(SE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
5.8K
Citations
28
h-index
33
i10-index
Katja Harbst is an academic researcher from Lund University. The author has contributed to research in topics: Melanoma and MAPK Pathways & Cancer Immunotherapy and Biomarkers & Cutaneous Melanoma Detection and Management. The author has an h-index of 28, co-authored 91 publications.
ORCID: 0000-0002-8225-1510Papers by this author
worksMutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
2017 · Nature Communications · 480 citations
https://doi.org/10.1038/s41467-017-01460-0
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population
2010 · Nature Genetics · 341 citations
https://doi.org/10.1038/ng.669
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
2009 · Human Molecular Genetics · 115 citations
https://doi.org/10.1093/hmg/ddp372
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers
2012 · Breast Cancer Research · 96 citations
https://doi.org/10.1186/bcr3121
Molecular patterns of resistance to immune checkpoint blockade in melanoma
2024 · Nature Communications · 48 citations
https://doi.org/10.1038/s41467-024-47425-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat